FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2790164088> ?p ?o ?g. }

• W2790164088 endingPage "986" @default.
• W2790164088 startingPage "982" @default.
• W2790164088 abstract "To analyse magnetic resonance angiographic (MRA) vessel wall signals from a randomized controlled trial of tocilizumab (TCZ) to treat GCA.Participants were assigned in a 2:1 ratio to receive either TCZ + glucocorticoids (GCs) or placebo + GC infusions at 4-week intervals for 52 weeks. GCs were started at 1 mg/kg/day, then tapered to 0.1 mg/kg/day at week 12 and thereafter down to zero. Patients with initial positive MRA findings underwent control MRA at weeks 12 and 52. Vessel wall signals were scored from 0 (normal) to 3 (intense late enhancement). Outcomes were the number of patients with complete MRA remission at weeks 12 and 52, and changes in vasculitis score, vessel anatomy and atherosclerosis.Of the 30 randomized participants, nine TCZ and two placebo patients had no vessel wall enhancement on initial MRA. At week 12, MRAs were performed in nine TCZ and four placebo patients (nine and three in clinical remission, respectively). Three (33%) TCZ patients showed normalization of vessel wall signals compared with one (25%) placebo patient. At week 52, there was additional MRA improvement in some TCZ patients, but one-third showed persistent or increased late vessel wall enhancement. There was no formation of aneurysms or stenosis and no increase in atherosclerosis.Although TCZ resulted in complete clinical and laboratory remission of GCA over 52 weeks, MRA signals in vessel walls normalized in only one-third of patients. Whether these signals are of prognostic importance remains to be determined." @default.
• W2790164088 created "2018-03-29" @default.
• W2790164088 creator A5021530218 @default.
• W2790164088 creator A5032983255 @default.
• W2790164088 creator A5034611564 @default.
• W2790164088 creator A5043087398 @default.
• W2790164088 creator A5049012434 @default.
• W2790164088 creator A5053278545 @default.
• W2790164088 creator A5081372430 @default.
• W2790164088 creator A5086602394 @default.
• W2790164088 date "2018-02-23" @default.
• W2790164088 modified "2023-10-14" @default.
• W2790164088 title "Magnetic resonance angiography in giant cell arteritis: results of a randomized controlled trial of tocilizumab in giant cell arteritis" @default.
• W2790164088 cites W1987192197 @default.
• W2790164088 cites W2004756447 @default.
• W2790164088 cites W2019029324 @default.
• W2790164088 cites W2053328369 @default.
• W2790164088 cites W2059547599 @default.
• W2790164088 cites W2093961109 @default.
• W2790164088 cites W2096059427 @default.
• W2790164088 cites W2127594841 @default.
• W2790164088 cites W2150186790 @default.
• W2790164088 cites W2150323580 @default.
• W2790164088 cites W2159897707 @default.
• W2790164088 cites W2165988999 @default.
• W2790164088 cites W2292169217 @default.
• W2790164088 cites W2466580064 @default.
• W2790164088 cites W2537085646 @default.
• W2790164088 doi "https://doi.org/10.1093/rheumatology/key015" @default.
• W2790164088 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29529280" @default.
• W2790164088 hasPublicationYear "2018" @default.
• W2790164088 type Work @default.
• W2790164088 sameAs 2790164088 @default.
• W2790164088 citedByCount "71" @default.
• W2790164088 countsByYear W27901640882018 @default.
• W2790164088 countsByYear W27901640882019 @default.
• W2790164088 countsByYear W27901640882020 @default.
• W2790164088 countsByYear W27901640882021 @default.
• W2790164088 countsByYear W27901640882022 @default.
• W2790164088 countsByYear W27901640882023 @default.
• W2790164088 crossrefType "journal-article" @default.
• W2790164088 hasAuthorship W2790164088A5021530218 @default.
• W2790164088 hasAuthorship W2790164088A5032983255 @default.
• W2790164088 hasAuthorship W2790164088A5034611564 @default.
• W2790164088 hasAuthorship W2790164088A5043087398 @default.
• W2790164088 hasAuthorship W2790164088A5049012434 @default.
• W2790164088 hasAuthorship W2790164088A5053278545 @default.
• W2790164088 hasAuthorship W2790164088A5081372430 @default.
• W2790164088 hasAuthorship W2790164088A5086602394 @default.
• W2790164088 hasBestOaLocation W27901640881 @default.
• W2790164088 hasConcept C126322002 @default.
• W2790164088 hasConcept C126838900 @default.
• W2790164088 hasConcept C142724271 @default.
• W2790164088 hasConcept C143409427 @default.
• W2790164088 hasConcept C168563851 @default.
• W2790164088 hasConcept C204787440 @default.
• W2790164088 hasConcept C27081682 @default.
• W2790164088 hasConcept C2776015282 @default.
• W2790164088 hasConcept C2776712624 @default.
• W2790164088 hasConcept C2777178219 @default.
• W2790164088 hasConcept C2777575956 @default.
• W2790164088 hasConcept C2778212899 @default.
• W2790164088 hasConcept C2779134260 @default.
• W2790164088 hasConcept C2781343717 @default.
• W2790164088 hasConcept C71924100 @default.
• W2790164088 hasConceptScore W2790164088C126322002 @default.
• W2790164088 hasConceptScore W2790164088C126838900 @default.
• W2790164088 hasConceptScore W2790164088C142724271 @default.
• W2790164088 hasConceptScore W2790164088C143409427 @default.
• W2790164088 hasConceptScore W2790164088C168563851 @default.
• W2790164088 hasConceptScore W2790164088C204787440 @default.
• W2790164088 hasConceptScore W2790164088C27081682 @default.
• W2790164088 hasConceptScore W2790164088C2776015282 @default.
• W2790164088 hasConceptScore W2790164088C2776712624 @default.
• W2790164088 hasConceptScore W2790164088C2777178219 @default.
• W2790164088 hasConceptScore W2790164088C2777575956 @default.
• W2790164088 hasConceptScore W2790164088C2778212899 @default.
• W2790164088 hasConceptScore W2790164088C2779134260 @default.
• W2790164088 hasConceptScore W2790164088C2781343717 @default.
• W2790164088 hasConceptScore W2790164088C71924100 @default.
• W2790164088 hasIssue "6" @default.
• W2790164088 hasLocation W27901640881 @default.
• W2790164088 hasLocation W27901640882 @default.
• W2790164088 hasLocation W27901640883 @default.
• W2790164088 hasOpenAccess W2790164088 @default.
• W2790164088 hasPrimaryLocation W27901640881 @default.
• W2790164088 hasRelatedWork W1188449285 @default.
• W2790164088 hasRelatedWork W1968260519 @default.
• W2790164088 hasRelatedWork W1985513194 @default.
• W2790164088 hasRelatedWork W2060750487 @default.
• W2790164088 hasRelatedWork W2792261031 @default.
• W2790164088 hasRelatedWork W2793684398 @default.
• W2790164088 hasRelatedWork W2883505650 @default.
• W2790164088 hasRelatedWork W2888746210 @default.
• W2790164088 hasRelatedWork W2953743969 @default.
• W2790164088 hasRelatedWork W3021594049 @default.
• W2790164088 hasVolume "57" @default.
• W2790164088 isParatext "false" @default.

• next